-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Initiates Coverage On Teva Pharmaceutical Indus with Buy Rating, Announces Price Target of $55

Benzinga·10/01/2026 13:28:48
Listen to the news
TD Cowen initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy rating and announces Price Target of $55.